KPV
Preclinical — Animal / cell-model data onlyWhat it is
A tripeptide fragment of alpha-MSH studied for anti-inflammatory activity, largely in animal and cell models.
KPV is a tripeptide fragment of alpha-MSH studied for anti-inflammatory activity, particularly in gut-inflammation models. It is small and stable.
Research context
Studied in relation to:
- Anti-inflammatory research
- Gut inflammation (animal)
Points in its favour in the literature:
- Reported anti-inflammatory action
- Small, stable peptide
Caveats and unknowns:
- Human data very limited
- Unlicensed for human use
- Effects not clinically established
Handling & reference data
Route in published researchSubcutaneous injection is the route most commonly described in the research literature. (oral is also used in some gut-focused research).
Published clinical / research context (not instructions)Reported in research around ~200–500 mcg daily.
Storage (lyophilised)Lyophilised (freeze-dried) powder: refrigerate at 2–8 °C short-term, or freeze at −20 °C or below for long-term storage. Keep sealed and out of light.
Reconstituted solutionOnce reconstituted: keep refrigerated (2–8 °C), protect from light, do not freeze. With bacteriostatic water, commonly used within ~4 weeks; with plain sterile water, within ~24–48 h.
Worked reconstitution example (arithmetic only)e.g. 10 mg vial + 2 mL → 5 mg/mL.
Available research formats
| Strength | SKU |
|---|---|
| 5mg | KPV5 |
| 10mg | KPV10 |
Current pricing (THB with USD/GBP conversion) is shown live in the catalogue, which also has a transparent U-100 reconstitution calculator.